ABSORB II: Seguimento de 2 anos não demonstrou superioridade do scaffold bioabsorvível eluidor de everolimus vs stent metálico eluidor everolimus em pacientes com doença arterial coronariana

Loading...

Bernard R. Chevalier

More articles by this author

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Use of DCB in Coronary Territory: Position Document of the Academic Research Consortium

The use of drug-coated balloons (DCB) is emerging as one of the most promising strategies in coronary angioplasty, particularly in clinical scenarios where avoiding...

IVUS Guided PCI: New Expansion Threshold

Intravascular ultrasound (IVUS) guided percutaneous coronary intervention (PCI) has been shown to improve clinical outcomes vs the conventional angiography guided PCI. This benefit has...

Use of Drug-Coated Balloons in Chronic Total Occlusions: The ERCTO Registry

Chronic total coronary occlusions (CTO) are still a major challenge in interventional cardiology, affecting 16%–18% of patients with coronary artery disease. While drug-eluting stents...